Optipharm.CO.,LTD (KOSDAQ:153710)

Optipharm.CO.,LTD Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	79,658	68,142	103,130	102,836	137,287	220,012
Market Cap Growth	2.65%	-33.93%	0.29%	-25.09%	-37.60%	69.27%
Enterprise Value	79,487	64,237	96,968	93,065	120,665	201,284
Last Close Price	5430.00	4645.00	7030.00	7010.00	9410.00	15200.00
PS Ratio	3.62	3.47	5.94	6.42	9.63	16.86
PB Ratio	3.10	2.49	4.10	3.55	4.43	6.51
P/TBV Ratio	3.13	2.52	4.15	3.58	4.47	6.57
EV/Sales Ratio	3.62	3.27	5.58	5.81	8.46	15.43
EV/FCF Ratio	-20.03	-	-	-	-	-
Debt / Equity Ratio	0.41	0.40	0.40	0.27	0.19	0.13
Net Debt / Equity Ratio	-0.01	-0.12	-0.22	-0.31	-0.52	-0.52
Net Debt / EBITDA Ratio	0.25	3.85	4.68	8.33	4.70	7.16
Net Debt / FCF Ratio	0.04	1.42	1.65	1.28	5.98	7.06
Asset Turnover	0.54	0.48	0.43	0.39	0.35	0.31
Inventory Turnover	9.65	11.20	10.90	11.41	11.87	13.72
Quick Ratio	1.01	1.23	1.49	2.02	2.97	4.20
Current Ratio	1.29	1.47	1.77	2.33	3.30	4.65
Return on Equity (ROE)	-9.71%	-8.98%	-9.00%	-6.82%	-9.52%	-6.78%
Return on Assets (ROA)	-3.59%	-3.71%	-4.09%	-3.32%	-6.83%	-5.20%
Return on Capital Employed (ROCE)	-8.00%	-8.00%	-9.50%	-6.90%	-13.50%	-9.60%
Earnings Yield	-2.99%	-3.46%	-2.36%	-1.99%	-2.24%	-1.07%
FCF Yield	-4.98%	-3.34%	-3.29%	-6.78%	-1.96%	-1.14%
Buyback Yield / Dilution	-0.15%	0.06%	-0.51%	-0.54%	-0.66%	-1.30%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.